You searched for "Retina"

1610 results found

The incidence of retinal vein occlusion in patients with pseudoexfoliation glaucoma

In this retrospective study the authors aimed to evaluate PXF as an independent risk factor for the occurrence of retinal vein occlusion (RVO). Three hundred PXF glaucoma patients (PXF group), 300 non-PXF glaucoma patients, and 599 non glaucoma non-PXF (nGnP...

Endo-illumination-aided SB combined with IVT hyaluronate for RRD

The authors report a retrospective non-randomised control trial that evaluated the efficacy and safety of 25-gauge illumination-aided scleral buckling (SB) combined with hyaluronate injection for the treatment of rhegmatogenous retinal detachment (RRD). Forty-five cases were included in this study. Twenty-five...

Intravitreal Bevacizumab for the prevention of postoperative proliferative vitreoretinopathy in high-risk patients

This single- centre observational retrospective study was conducted to evaluate the effect of intravitreal injection of bevacizumab at the time surgery for rhegmatogenous retinal detachment (RRD) repair on postoperative proliferative vitreoretinopathy (PVR) in patients at high risk selected by laser...

Joe Scott joins Mainline Instruments as Retinal Product Specialist

Mainline Instruments welcomes the new appointment of Joe Scott to the Mainline Sales Team as Retinal Product Specialist. We believe that through his experience, Joe has the knowledge and skillset to deliver real value to our customers and staff.

Practice Plus Group: CSR in primary care optometry

Practice Plus Group Ophthalmology are delighted to offer a virtual accredited event for local referrers: ‘CSR in primary care optometry’Central serous retinopathy (CSR) is the fourth most common medical retinal condition which affects mainly patients of working age. It is...

World’s largest vision award goes to Botond Roska and José-Alain Sahel

Botond Roska, Director of Science at the Institute of Molecular and Clinical Ophthalmology Basel (IOB), and José-Alain Sahel, University of Pittsburgh and Chair of the IOB Scientific Advisory Board, have been awarded the 2026 António Champalimaud Vision Award. Worth EUR...

Predictive value of OCT biomarkers on visual outcome in retinal vein occlusion

This was a retrospective study. The cohort included 163 eyes from patients diagnosed with retinal vein occlusion (RVO) aged 18 years or older. The primary endpoints were the mean change in best corrected visual acuity (BCVA) at baseline to follow-up...

Malignant hypertension presenting as bilateral optic disc swelling detected during diabetic retinal screening

A 48-year-old woman was referred from the diabetic retinopathy screening programme to the eye casualty service following the incidental finding of bilateral optic disc swelling. Mild background diabetic retinopathy was present, and she was otherwise initially asymptomatic. Due to concern...

My Top Five: Key insights from recent research into uveitis in adults

Uveitis, characterised by inflammation of the uvea – the eye’s middle layer comprising the iris, ciliary body, and choroid – remains a leading cause of visual impairment worldwide [1]. It primarily affects adults aged 20–50 years. Untreated uveitis may cause...

Emerging therapies for geographic atrophy: complement inhibitors show potential to slow progression and preserve RPE and photoreceptor integrity

Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) characterised by progressive, irreversible loss of the retinal pigment epithelium (RPE) and photoreceptors and is estimated to account for approximately 10% of AMD-related blindness [1-4]. The Age-Related Eye...

Innovative 3D printing could revolutionise treatment for cataracts and other eye conditions

University of East Anglia researchers have made a significant breakthrough in ocular device technology with the introduction of a novel resin for 3D printing intraocular devices. This innovation has potential to enhance the manufacture of eye implants universally used in cataract and refractive surgeries.

BOAS 2025 Annual Scientific Meeting

We are excited to announce the upcoming 23rd BOAS Annual Scientific Meeting, which will be held at the prestigious Royal Society of Medicine in London on Thursday 4th and Friday 5th September 2025. This event offers an exceptional opportunity for...